{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:58:39Z","timestamp":1792645119041,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.rdc.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T20:42:47Z","timestamp":1458160967000},"page":"265-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Patient-Reported Outcomes in Psoriatic Arthritis"],"prefix":"10.1016","volume":"42","author":[{"given":"Ana-Maria","family":"Orbai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ogdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rdc.2016.01.002_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3899\/jrheum.091315","article-title":"Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health","volume":"37","author":"Taylor","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib2","first-page":"1167","article-title":"Consensus on a core set of domains for psoriatic arthritis","volume":"34","author":"Gladman","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11926-014-0418-7","article-title":"Patient involvement in outcome measures for psoriatic arthritis","volume":"16","author":"Tillett","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A\u00a0patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2016.01.002_bib5","first-page":"S64","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3899\/jrheum.100857","article-title":"Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study","volume":"38","author":"Cauli","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib7","first-page":"177","article-title":"MDHAQ\/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter","volume":"70","author":"Pincus","year":"2012","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.002_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.002_bib9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2105\/AJPH.72.8.800","article-title":"Self-rated health: a predictor of mortality among the elderly","volume":"72","author":"Mossey","year":"1982","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.002_bib13","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3899\/jrheum.101256","article-title":"Minimal important difference and responsiveness to change of the SF-36 in patients with psoriatic arthritis receiving tumor necrosis factor-alpha blockers","volume":"38","author":"Leung","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.002_bib14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M","article-title":"Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis","volume":"43","author":"Kosinski","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr.20104","article-title":"Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies","volume":"62","author":"Saad","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.002_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2011-200387","article-title":"Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment","volume":"71","author":"Strand","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.injury.2010.11.052","article-title":"Measuring hip outcomes: common scales and checklists","volume":"42","author":"Ahmad","year":"2011","journal-title":"Injury"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3899\/jrheum.120782","article-title":"Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study","volume":"40","author":"Leung","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2016.01.002_bib19","first-page":"S308","volume":"63","author":"Gignac","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib20","first-page":"1015","article-title":"Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic arthritis","volume":"23","author":"Husted","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.002_bib21","first-page":"1932","article-title":"Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis","volume":"23","author":"Husted","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib22","first-page":"958","article-title":"The relationship between patient satisfaction with health and clinical measures of function and disease status in patients with psoriatic arthritis","volume":"27","author":"Long","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.2003.006296","article-title":"Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis","volume":"63","author":"McKenna","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/03009740903468982","article-title":"Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey","volume":"39","author":"Brodszky","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03009740903347975","article-title":"Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) instrument for Sweden","volume":"39","author":"Billing","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib26","doi-asserted-by":"crossref","first-page":"e55912","DOI":"10.1371\/journal.pone.0055912","article-title":"Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire","volume":"8","author":"Wink","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.002_bib28","first-page":"1613","article-title":"Comparison of 4 functional indexes in psoriatic arthritis with axial or peripheral disease subgroups using Rasch analyses","volume":"35","author":"Leung","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.002_bib29","first-page":"2146","article-title":"Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis","volume":"25","author":"Husted","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib30","first-page":"511","article-title":"Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis","volume":"24","author":"Husted","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2003.014522","article-title":"Sensitivity to change of AIMS2 and AIMS2-SF components in comparison to M-HAQ and VAS-pain","volume":"63","author":"Taal","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/rheumatology\/kes355","article-title":"Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis","volume":"52","author":"Chaudhry","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/acr.22401","article-title":"Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients","volume":"67","author":"Eder","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.22443","article-title":"A\u00a0longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time?","volume":"56","author":"Husted","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0b013e3182936b98","article-title":"MDHAQ\/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis","volume":"19","author":"Castrejon","year":"2013","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.002_bib36","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3899\/jrheum.080182","article-title":"RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories","volume":"35","author":"Pincus","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.002_bib37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/acr.20481","volume":"63","author":"Pincus","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3899\/jrheum.121059","article-title":"Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort","volume":"40","author":"Castrejon","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10067-014-2827-4","article-title":"Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis","volume":"34","author":"Danve","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/acr.21793","article-title":"Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis","volume":"65","author":"Castrejon","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2016.01.002_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12891-015-0512-7","article-title":"Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)","volume":"16","author":"Leeb","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib42","first-page":"2286","article-title":"A\u00a0new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.20421","article-title":"Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?","volume":"51","author":"Taylor","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.20017","article-title":"Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis","volume":"62","author":"Fernandez-Sueiro","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib45","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/ard.2010.129726","article-title":"Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?","volume":"69","author":"Eder","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.002_bib47","first-page":"1480","article-title":"The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis","volume":"15","author":"Wolfe","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keu284","article-title":"Relationship between types of radiographic damage and disability in patients with rheumatoid arthritis in the EURIDISS cohort: a longitudinal study","volume":"54","author":"Navarro-Compan","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.002_bib49","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/annrheumdis-2013-205079","article-title":"Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials","volume":"74","author":"Ward","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.002_bib50","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3899\/jrheum.110546","article-title":"Minimally important difference of Health Assessment Questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfaction","volume":"38","author":"Mease","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.22770","article-title":"Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis","volume":"57","author":"Taylor","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib52","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.23520","article-title":"Comparison of the health assessment questionnaire disability index and the short form 36 physical functioning subscale using Rasch analysis: comment on the article by Taylor and McPherson","volume":"59","author":"Fries","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib53","first-page":"2281","article-title":"A\u00a0new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index","volume":"21","author":"Calin","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib54","first-page":"680","article-title":"The burden of psoriatic arthritis: a literature review from a global health systems perspective","volume":"35","author":"Lee","year":"2010","journal-title":"P\u00a0T"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.002_bib55","first-page":"2191","article-title":"Validity assessment of the disabilities of arm, shoulder, and hand questionnaire (DASH) for patients with psoriatic arthritis","volume":"26","author":"Navsarikar","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2165\/00019053-199610060-00010","article-title":"The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis","volume":"10","author":"Nichol","year":"1996","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.12106","article-title":"Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies","volume":"28","author":"Mattei","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/000155500300012873","article-title":"Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity","volume":"80","author":"Lundberg","year":"2000","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib60","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s11136-013-0527-1","article-title":"Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory","volume":"23","author":"Bushnell","year":"2014","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09546634.2012.759639","article-title":"Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity","volume":"24","author":"Martin","year":"2013","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/09546634.2012.742950","article-title":"Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity","volume":"24","author":"Bushnell","year":"2013","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib63","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/acr.22653","article-title":"Reliability and validity of the psoriasis symptom inventory in patients with psoriatic arthritis","volume":"67","author":"Wilson","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib64","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/ijd.12645","article-title":"The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis","volume":"54","author":"Naegeli","year":"2015","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.002_bib66","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2006.065763","article-title":"Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis","volume":"66","author":"Chandran","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib67","first-page":"811","article-title":"Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis","volume":"32","author":"Cella","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2016.01.002_bib68","first-page":"S263","volume":"63","author":"Hewlett","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/rheumatology\/ker216","article-title":"Work disability in psoriatic arthritis: a systematic review","volume":"51","author":"Tillett","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.002_bib70","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/annrheumdis-2012-202229","article-title":"Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study","volume":"72","author":"Kristensen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib71","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar2702","article-title":"Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA)","volume":"11","author":"Osterhaus","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib72","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar4602","article-title":"Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity in patients with psoriatic arthritis","volume":"16","author":"Osterhaus","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.002_bib73","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/rheumatology\/keq112","article-title":"Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis","volume":"49","author":"Leung","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","article-title":"Methods for assessing responsiveness: a critical review and recommendations","volume":"53","author":"Husted","year":"2000","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib75","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3899\/jrheum.090832","article-title":"Minimally important difference for patient-reported outcomes in psoriatic arthritis: health assessment questionnaire and pain, fatigue, and global visual analog scales","volume":"37","author":"Kwok","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.002_bib76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2008.10.059","article-title":"Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis","volume":"60","author":"Callis Duffin","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib77","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/bjd.12000","article-title":"Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial","volume":"167","author":"Strober","year":"2012","journal-title":"Br J Dermatol"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2016.01.002_bib78","first-page":"S86","article-title":"Measures of fibromyalgia: fibromyalgia impact questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ)","volume":"63","author":"Williams","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib79","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3899\/jrheum.100479","article-title":"Informing response criteria for psoriatic arthritis (PsA). II: further considerations and a proposal\u2013the PsA joint activity index","volume":"37","author":"Gladman","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib80","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.002_bib82","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/ard.2009.117945","article-title":"Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis","volume":"69","author":"Nell-Duxneuner","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.002_bib83","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib84","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3899\/jrheum.140172","article-title":"Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response","volume":"41","author":"Helliwell","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.002_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.6515","article-title":"Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score","author":"Schoels","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.002_bib86","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.2010.129379","article-title":"Development of a preliminary composite disease activity index in psoriatic arthritis","volume":"70","author":"Mumtaz","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.002_bib87","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","article-title":"The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)","volume":"72","author":"Helliwell","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.002_bib88","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/acr.22204","article-title":"Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab","volume":"66","author":"Helliwell","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.002_bib90","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/art.1780391210","article-title":"Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs cooperative study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.002_bib91","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/ard.2006.051706","article-title":"Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors","volume":"65","author":"Fransen","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.002_bib92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","article-title":"Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)","volume":"73","author":"Mease","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9227","key":"10.1016\/j.rdc.2016.01.002_bib93","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.002_bib94","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3899\/jrheum.091172","article-title":"Informing response criteria for psoriatic arthritis. I: discrimination models based on data from 3 anti-tumor necrosis factor randomized studies","volume":"37","author":"Gladman","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.002_bib95","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3899\/jrheum.100069","article-title":"Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study","volume":"37","author":"Gladman DD1; ACCLAIM Study Investigators","year":"2010","journal-title":"J Rheumatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1600003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1600003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:19Z","timestamp":1760181199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X1600003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0889857X1600003X"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.01.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcomes in Psoriatic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}